市場調査レポート

商品コード

1461247

ノルトリプチリン塩酸塩の世界市場：純度別、形態別、用途別、地域別の機会および予測 (2017～2031年)

Nortriptyline Hydrochloride Market Assessment, By Purity, By Form, By Application, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年04月09日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 232 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 715,365円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 906,129円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,303,554円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=158.97円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のノルトリプチリン塩酸塩の市場規模は、予測期間の2024年～2031年に2.3%のCAGRで拡大し、2023年の2億3,970万米ドルから2031年には2億8,752万米ドルに成長すると予測されています。市場成長の背景には、神経痛の増加やうつ病などの気分障害の有病率の上昇があります。

ノルトリプチリンは、シナプス前神経細胞膜によるノルエピネフリンとセロトニンの再取り込みを阻害し、シナプス内のこれらの神経伝達物質の濃度を上昇させます。ノルトリプチリンはアセチルコリン、ヒスタミン、5-ヒドロキシトリプタミンの活性も阻害します。世界中の様々な地域でうつ病の有病率が上昇していることは、市場の成長を促進している主要な市場動向の一つです。例えば、世界保健機関（WHO）の推計によると、世界の成人人口の約5％がうつ病を患っています。うつ病は男性に比べて女性に50％多く見られます。アミトリプチリンの活性代謝物であるノルトリプチリン塩酸塩は三環系抗うつ薬として作用し、大うつ病の治療に使用されるため、うつ病を患う人の増加は市場に有利な成長機会を提供します。

神経障害性疼痛を患う患者の増加も、ノルトリプチリン塩酸塩の世界市場規模を押し上げる大きな要因です。ノルトリプチリンは、後根神経節内で非神経サテライト細胞に発現するB2アドレナリン受容体に作用するノルアドレナリンレベルを上昇させることにより、神経障害性疼痛を軽減します。B2-アドレナリン受容体を刺激することにより、神経障害によるTNFaの産生が減少し、神経障害性疼痛が緩和されます。ノルトリプチリンは通常、溶液またはカプセルとして経口投与されます。カプセルは75mg、50mg、25mg、10mgなど様々な強さで入手可能であり、溶液は10mg/5mL（473mL）の組成で入手可能です。したがって、神経障害性疼痛を患う患者の増加により、ノルトリプチリン塩酸塩への需要が高まり、疼痛管理用医薬品の生産が促進され、市場に有利な成長機会がもたらされています。

当レポートでは、世界のノルトリプチリン塩酸塩市場について調査し、市場の概要とともに、純度別、形態別、用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1.Global Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 2.Global Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 3.Global Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 4.Global Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 5.Global Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 6.Global Nortriptyline Hydrochloride Market Share (%), By Region, 2017-2031F
Figure 7.North America Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 8.North America Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 9.North America Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 10.North America Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 11.North America Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 12.North America Nortriptyline Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 13.United States Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 14.United States Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 15.United States Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 16.United States Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 17.United States Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 18.Canada Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 19.Canada Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 20.Canada Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 21.Canada Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 22.Canada Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 23.Mexico Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 24.Mexico Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 25.Mexico Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 26.Mexico Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 27.Mexico Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 28.Europe Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 29.Europe Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 30.Europe Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 31.Europe Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 32.Europe Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 33.Europe Nortriptyline Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 34.Germany Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 35.Germany Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 36.Germany Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 37.Germany Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 38.Germany Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 39.France Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 40.France Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 41.France Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 42.France Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 43.France Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 44.Italy Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 45.Italy Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 46.Italy Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 47.Italy Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 48.Italy Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 49.United Kingdom Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 50.United Kingdom Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 51.United Kingdom Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 52.United Kingdom Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 53.United Kingdom Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 54.Russia Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 55.Russia Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 56.Russia Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 57.Russia Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 58.Russia Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 59.Netherlands Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 60.Netherlands Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 61.Netherlands Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 62.Netherlands Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 63.Netherlands Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 64.Spain Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 65.Spain Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 66.Spain Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 67.Spain Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 68.Spain Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 69.Turkey Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 70.Turkey Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 71.Turkey Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 72.Turkey Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 73.Turkey Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 74.Poland Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 75.Poland Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 76.Poland Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 77.Poland Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 78.Poland Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 79.South America Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 80.South America Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 81.South America Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 82.South America Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 83.South America Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 84.South America Nortriptyline Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 85.Brazil Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 86.Brazil Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 87.Brazil Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 88.Brazil Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 89.Brazil Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 90.Argentina Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 91.Argentina Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 92.Argentina Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 93.Argentina Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 94.Argentina Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 95.Asia-Pacific Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 96.Asia-Pacific Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 97.Asia-Pacific Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 98.Asia-Pacific Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 99.Asia-Pacific Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 100.Asia-Pacific Nortriptyline Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 101.India Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 102.India Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 103.India Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 104.India Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 105.India Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 106.China Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 107.China Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 108.China Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 109.China Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 110.China Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 111.Japan Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 112.Japan Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 113.Japan Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 114.Japan Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 115.Japan Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 116.Australia Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 117.Australia Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 118.Australia Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 119.Australia Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 120.Australia Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 121.Vietnam Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 122.Vietnam Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 123.Vietnam Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 124.Vietnam Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 125.Vietnam Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 126.South Korea Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 127.South Korea Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 128.South Korea Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 129.South Korea Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 130.South Korea Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 131.Indonesia Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 132.Indonesia Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 133.Indonesia Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 134.Indonesia Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 135.Indonesia Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 136.Philippines Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 137.Philippines Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 138.Philippines Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 139.Philippines Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 140.Philippines Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 141.Middle East & Africa Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 142.Middle East & Africa Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 143.Middle East & Africa Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 144.Middle East & Africa Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 145.Middle East & Africa Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 146.Middle East & Africa Nortriptyline Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 147.Saudi Arabia Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 148.Saudi Arabia Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 149.Saudi Arabia Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 150.Saudi Arabia Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 151.Saudi Arabia Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 152.UAE Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 153.UAE Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 154.UAE Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 155.UAE Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 156.UAE Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 157.South Africa Nortriptyline Hydrochloride Market, By Value, in USD Million, 2017-2031F
Figure 158.South Africa Nortriptyline Hydrochloride Market, By Volume, in Kilotons, 2017-2031F
Figure 159.South Africa Nortriptyline Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 160.South Africa Nortriptyline Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 161.South Africa Nortriptyline Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 162.By Purity Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 163.By Form Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 164.By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 165.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Product Code: MX11248

Global nortriptyline hydrochloride market is projected to witness a CAGR of 2.3% during the forecast period 2024-2031, growing from USD 239.7 million in 2023 to USD 287.52 million in 2031F. The market growth is aided by increasing incidences of nerve pain and the rising prevalence of mood disorders such as depression.

Nortriptyline inhibits the reuptake of norepinephrine and serotonin by the presynaptic neuronal membrane, resulting in an increased concentration of these neurotransmitters in the synapse. Nortriptyline also inhibits the activity of acetylcholine, histamine, and 5-hydroxytryptamine. The increasing prevalence of depression in various regions around the globe is one of the major market trends that is fostering market growth. For instance, according to the estimates of the World Health Organization (WHO), approximately 5% of the adult global population suffers from depression. It is 50% more common in women as compared to men. This increase in the number of individuals suffering from depression will provide lucrative growth opportunities to the market as nortriptyline hydrochloride, an active metabolite of amitriptyline acts as a tricyclic antidepressant and is used for treating major depression.

The rise in incidences of individuals suffering from neuropathic pain is another major factor bolstering the global nortriptyline hydrochloride market size. Nortriptyline reduces neuropathic pain by increasing noradrenaline levels that act within the dorsal root ganglia on B2-adrenoceptors expressed by the non-neuronal satellite cells. Stimulating B2-adrenoceptors results in the reduced neuropathy-induced production of TNFa, thereby relieving neuropathic pain. Nortriptyline is usually administered orally as a solution or a capsule. The capsule is available in varying strengths including 75 mg, 50 mg, 25 mg, and 10 mg and the solution is available in the composition of 10mg/ 5mL (473 mL). Hence, due to the increasing cases of individuals suffering from neuropathic pain, the requirement for nortriptyline hydrochloride is rising to support the production of medication for pain management, thereby providing lucrative growth opportunities to the market.

Growing Prevalence of Depression Supports Global Nortriptyline Hydrochloride Market Growth

The nortriptyline hydrochloride treats depression by increasing the quantity of norepinephrine and serotonin in the brain, the substances that are responsible for regulating mood. Thus, supporting the market's growth by propelling the demand for nortriptyline hydrochloride. The dosage of the medication is based on the condition of the patient and their response to the treatment. The dose of the medication is directed at a lower range which is then increased gradually to reduce the risk of side effects associated with the medication.

The susceptibility of the contemporary population to depression is growing due to several factors including intense individual competitiveness, rising social failure, low social support, and increased inequality. For instance, according to the estimates of the World Health Organization (WHO), approximately 3.8% of the population suffers from depression. This includes 5% of the adult population of which 5.7% are older than 60 years. Nearly 280 million individuals across the globe are living with depression. Hence, this increase will augment the requirement for nortriptyline hydrochloride as the product belongs to a group of medications that are known as tricyclic antidepressants.

Increasing Incidences of Diabetic Neuropathy Boosts Global Nortriptyline Hydrochloride Market Demand

The presence of high blood glucose levels and fats, including triglycerides in blood due to diabetes can result in nerve damage causing diabetic neuropathy. High blood sugar levels can also cause damage to the blood vessels that provide the nerves with nutrients and oxygen. For instance, according to the estimates of the National Institute of Diabetes and Digestive and Kidney Diseases, approximately 30% of the individuals suffering from diabetes have automatic neuropathy. This, in turn, is bolstering the requirement for nortriptyline hydrochloride to support the production of medication for managing diabetic neuropathy. Henceforth, augmenting the market demand in various regions across the globe.

Meanwhile, the rising consumption of food products with high amounts of sugar and carbonated beverages coupled with changing lifestyle patterns are increasing the number of individuals suffering from diabetes. This, in turn, is propelling the incidences of diabetic neuropathy, bolstering the product demand to ensure the production of appropriate medication to support the management of the condition. For instance, according to the projections of the International Diabetes Federation, by 2045, approximately 783 million people, 1 in 8 adults, will be living with diabetes. As the incidences of diabetes increase, the cases of diabetic neuropathy will also increase, thus augmenting the global nortriptyline hydrochloride market growth.

North America Accounts for Significant Market Share

The presence of a well-established healthcare sector and increasing investments by various pharmaceutical, healthcare, and biotechnology companies towards research and development activities is bolstering the demand for nortriptyline hydrochloride in various countries in North America. The increasing prevalence of depression in the region is further supporting the market expansion. For instance, according to the estimates of Mental Health America, more than 8% of American adults, approximately 21 million individuals are affected by depression. This increased prevalence coupled with the easy accessibility to various medications that help in treating depression are supporting the market growth as nortriptyline hydrochloride works as a tricyclic antidepressant. Therefore, the increasing incidences of individuals suffering from chronic pain is another major factor supporting the market expansion in the region, as the product finds applications in various medications that are used for treating chronic pain.

Rising Demand for More than 99% Nortriptyline Hydrochloride Boosts Market Growth

The increasing requirement for nortriptyline hydrochloride with more than 99% purity can be attributed to their rising demand by academic and research institutions and medicine manufacturing facilities in various regions across the globe. The pharmaceutical sector is significantly growing in various regions, for instance, according to the estimates of The Association of the British Pharmaceutical Industry, the pharmaceutical industry spends approximately USD 160 billion every year on research and development activities as the development of novel medications involves significant rates of failure. Due to such growing efforts and investments in medicine manufacturing, the requirement for nortriptyline hydrochloride will increase, thus propelling the growth of the market. The preference for nortriptyline hydrochloride with more than 99% purity can also be attributed to the high efficacy offered by the product as opposed to their counterparts, thus augmenting their demand, and supporting the expansion of the market.

Capsules Account for Significant Global Nortriptyline Hydrochloride Market Share

The expansion of the segment can be attributed to the higher bioavailability offered by the capsules as opposed to their counterparts, making them more effective than tablets. The nortriptyline hydrochloride capsules contain various inactive ingredients including sodium lauryl sulfate, colloidal silicon dioxide, pregelatinized starch, and magnesium stearate. For instance, the 75 mg, 50 mg, 25 mg, and 10 mg capsule shells contain titanium dioxide, gelatin, sodium lauryl sulfate, propylparaben, and methylparaben. They can also contain edetate calcium disodium, benzyl alcohol, silicon dioxide or sodium propionate, and butylparaben. The 75 mg, 25 mg, and 10 mg capsule shells also contain FD&C Blue No. 1 and D&C Yellow No. 10. The nortriptyline hydrochloride is usually prescribed for the smallest quantity of capsules with good patient management, to reduce the risk of overdose. Thus, the increased accessibility to nortriptyline hydrochloride capsules coupled with the rising awareness about mental health and depression are supporting the growth of the segment, thus boosting the market expansion.

Future Market Scenario (2024-2031F)

According to the global nortriptyline hydrochloride market analysis, the demand for nortriptyline hydrochloride will increase over the forecast period due to increasing research and development activities and utilization of the product for drug repurposing. Various studies are being conducted to evaluate the potential candidacy of nortriptyline hydrochloride for repurposing of drugs. For instance, according to an article published by researchers from the Department of Oncology, the Affiliated Hospital of Qingdao University, Qingdao, China, nortriptyline hydrochloride exhibits significant antitumor activities in both in-vitro and in-vivo. The product can inhibit gastric cancer by inducing oxidative stress and apoptosis. Conduction of such studies will bolster the requirement for nortriptyline hydrochloride over the forecast period by academic and research institutions augmenting the market demand.

Key Players Landscape and Outlook

The companies are undergoing continuous research and development. Furthermore, they are collaborating with other companies and organizations to support their R&D activities. Such initiatives will provide lucrative growth opportunities for the market as at times such efforts bring economies of scope that would not have been possible through organic growth. Thus, supporting the expansion of the global nortriptyline hydrochloride market.

In October 2023, Viatris Inc., one of the leading healthcare and pharmaceutical corporations, announced that they would be selling their Active Pharmaceutical Ingredients (API) business to Iquest Enterprises. The transaction includes a research and development lab and three manufacturing sites in Hyderabad, third-party API sales, and three manufacturing sites in Vizag.

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

4.1.Market Awareness and Product Information
4.2.Brand Awareness and Loyalty
4.3.Factors Considered in Purchase Decision
- 4.3.1.Brand Name
- 4.3.2.Quality
- 4.3.3.Quantity
- 4.3.4.Price
- 4.3.5.Product Specification
- 4.3.6.Form Specification
- 4.3.7.Shelf Life
- 4.3.8.Availability of Product
4.4.Frequency of Purchase
4.5.Medium of Purchase

5.Global Nortriptyline Hydrochloride Market Outlook, 2017-2031F

5.1.Market Size & Forecast
- 5.1.1.By Value
- 5.1.2.By Volume
5.2.By Purity
- 5.2.1. Less than 98%
- 5.2.2.98%
- 5.2.3.98.1% to 99%
- 5.2.4.More than 99%
5.3.By Form
- 5.3.1.Capsule
- 5.3.2.Tablet
- 5.3.3.Others
5.4.By Application
- 5.4.1.Medicine Manufacturing
- 5.4.2.Research and Academics
- 5.4.3.Others
5.5.By Region
- 5.5.1.North America
- 5.5.2.South America
- 5.5.3.Europe
- 5.5.4.Asia-Pacific
- 5.5.5.Middle East & Africa
5.6.By Company Market Share (%), 2023

6.Global Nortriptyline Hydrochloride Market Outlook, By Region, 2017-2031F

6.1.North America*
- 6.1.1.Market Size & Forecast
  - 6.1.1.1.By Value
  - 6.1.1.2.By Volume
- 6.1.2.By Purity
  - 6.1.2.1.Less than 98%
  - 6.1.2.2.98%
  - 6.1.2.3.98.1% to 99%
  - 6.1.2.4.More than 99%
- 6.1.3.By Form
  - 6.1.3.1.Capsule
  - 6.1.3.2.Tablet
  - 6.1.3.3.Others
- 6.1.4.By Application
  - 6.1.4.1.Medicine Manufacturing
  - 6.1.4.2.Research and Academics
  - 6.1.4.3.Others
- 6.1.5.United States*
  - 6.1.5.1.Market Size & Forecast
  - 6.1.5.1.1.By Value
  - 6.1.5.1.2.By Volume
  - 6.1.5.2.By Purity
  - 6.1.5.2.1.Less than 98%
  - 6.1.5.2.2.98%
  - 6.1.5.2.3.98.1% to 99%
  - 6.1.5.2.4.More than 99%
  - 6.1.5.3.By Form
  - 6.1.5.3.1.Capsule
  - 6.1.5.3.2.Tablet
  - 6.1.5.3.3.Others
  - 6.1.5.4.By Application
  - 6.1.5.4.1.Medicine Manufacturing
  - 6.1.5.4.2.Research and Academics
  - 6.1.5.4.3.Others
- 6.1.6.Canada
- 6.1.7.Mexico

All segments will be provided for all regions and countries covered

6.2.Europe
- 6.2.1.Germany
- 6.2.2.France
- 6.2.3.Italy
- 6.2.4.United Kingdom
- 6.2.5.Russia
- 6.2.6.Netherlands
- 6.2.7.Spain
- 6.2.8.Turkey
- 6.2.9.Poland
6.3.Asia-Pacific
- 6.3.1.India
- 6.3.2.China
- 6.3.3.Japan
- 6.3.4.Australia
- 6.3.5.Vietnam
- 6.3.6.South Korea
- 6.3.7.Indonesia
- 6.3.8.Philippines
6.4.South America
- 6.4.1.Brazil
- 6.4.2.Argentina
6.5.Middle East & Africa
- 6.5.1.Saudi Arabia
- 6.5.2.UAE
- 6.5.3.South Africa

7.Supply Side Analysis

7.1.Capacity, By Company
7.2.Production, By Company
7.3.Operating Efficiency, By Company
7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

8.1.By Purity
8.2.By Form
8.3.By Application
8.4.By Region

9.Macro Environment and Industry Structure

9.1.Supply Demand Analysis
9.2.Import Export Analysis
9.3.Value Chain Analysis
9.4.PESTEL Analysis
- 9.4.1.Political Factors
- 9.4.2.Economic System
- 9.4.3.Social Implications
- 9.4.4.Technological Advancements
- 9.4.5.Environmental Impacts
- 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
9.5.Porter's Five Forces Analysis
- 9.5.1.Supplier Power
- 9.5.2.Buyer Power
- 9.5.3.Substitution Threat
- 9.5.4.Threat from New Entrant
- 9.5.5.Competitive Rivalry

10.Market Dynamics

10.1.Growth Drivers
10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

11.1.Competition Matrix of Top Five Market Leaders
11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4.SWOT Analysis (For Five Market Players)
11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

14.1.Anant Pharmaceuticals Pvt. Ltd.
- 14.1.1.Company Details
- 14.1.2.Key Management Personnel
- 14.1.3.Products & Services
- 14.1.4.Financials (As reported)
- 14.1.5.Key Market Focus & Geographical Presence
- 14.1.6.Recent Developments
14.2.HRV Global Life Sciences
14.3.Vasudha Pharma Chem Ltd.
14.4.Centaur Pharmaceuticals Pvt. Ltd.
14.5.Dipharma Inc.
14.6.Taro Pharmaceutical Industries Ltd.
14.7.Sigma-Aldrich (Merck Group)
14.8.LGM Pharma
14.9.Tiefenbacher API + Ingredients GmbH & Co. KG
14.10.Tokyo Chemical Industry (India) Pvt. Ltd. (Tokyo Chemical Industry Co., Ltd.)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

ノルトリプチリン塩酸塩の世界市場：純度別、形態別、用途別、地域別の機会および予測 (2017～2031年)

Nortriptyline Hydrochloride Market Assessment, By Purity, By Form, By Application, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章顧客の声

第5章世界のノルトリプチリン塩酸塩市場の見通し、2017年～2031年

第6章世界のノルトリプチリン塩酸塩市場の見通し、地域別、2017年～2031年

第7章供給側分析

第8章 2023年の市場マッピング

第9章マクロ環境と産業構造

第10章市場力学

第11章主要参入企業の情勢

第12章価格分析

第13章ケーススタディ

第14章主要参入企業の見通し

第15章戦略的提言

第16章お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

5.Global Nortriptyline Hydrochloride Market Outlook, 2017-2031F

6.Global Nortriptyline Hydrochloride Market Outlook, By Region, 2017-2031F

7.Supply Side Analysis

8.Market Mapping, 2023

9.Macro Environment and Industry Structure

10.Market Dynamics

11.Key Players Landscape

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

15.Strategic Recommendations

16.About Us & Disclaimer

ノルトリプチリン塩酸塩の世界市場：純度別、形態別、用途別、地域別の機会および予測 (2017～2031年)

Nortriptyline Hydrochloride Market Assessment, By Purity, By Form, By Application, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のノルトリプチリン塩酸塩市場の見通し、2017年～2031年

第6章 世界のノルトリプチリン塩酸塩市場の見通し、地域別、2017年～2031年

第7章 供給側分析

第8章 2023年の市場マッピング

第9章 マクロ環境と産業構造

第10章 市場力学

第11章 主要参入企業の情勢

第12章 価格分析

第13章 ケーススタディ

第14章 主要参入企業の見通し

第15章 戦略的提言

第16章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

5.Global Nortriptyline Hydrochloride Market Outlook, 2017-2031F

6.Global Nortriptyline Hydrochloride Market Outlook, By Region, 2017-2031F

7.Supply Side Analysis

8.Market Mapping, 2023

9.Macro Environment and Industry Structure

10.Market Dynamics

11.Key Players Landscape

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

15.Strategic Recommendations

16.About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章顧客の声

第5章世界のノルトリプチリン塩酸塩市場の見通し、2017年～2031年

第6章世界のノルトリプチリン塩酸塩市場の見通し、地域別、2017年～2031年

第7章供給側分析

第9章マクロ環境と産業構造

第10章市場力学

第11章主要参入企業の情勢

第12章価格分析

第13章ケーススタディ

第14章主要参入企業の見通し

第15章戦略的提言

第16章お問い合わせと免責事項